Hollencrest Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Hollencrest Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-82,500	Closed	-$3.82M	–	338
2019 Q2	$3.82M	Sell	82,500 -3,145	-4%	-$88.3K	0.48%	36
2019 Q1	$2.09M	Hold	85,645	–	–	0.28%	58
2018 Q4	$1.22M	Hold	85,645	–	–	0.18%	84
2018 Q3	$2.09M	Sell	85,645 -55,825	-39%	-$855K	0.28%	58
2018 Q2	$2.37M	Hold	141,470	–	–	0.31%	58
2018 Q1	$2.31M	Hold	141,470	–	–	0.3%	63
2017 Q4	$1.81M	Hold	141,470	–	–	0.24%	71
2017 Q3	$1.74M	Hold	141,470	–	–	0.24%	74
2017 Q2	$1.18M	Hold	141,470	–	–	0.18%	91
2017 Q1	$1.26M	Hold	141,470	–	–	0.18%	90
2016 Q4	$1.24M	Sell	141,470 -28,530	-17%	-$210K	0.19%	91
2016 Q3	$1.15M	Hold	170,000	–	–	0.17%	107
2016 Q2	$605K	Hold	170,000	–	–	0.09%	169
2016 Q1	$502K	Hold	170,000	–	–	0.09%	177
2015 Q4	$717K	Hold	170,000	–	–	0.13%	138
2015 Q3	$775K	Hold	170,000	–	–	0.13%	118
2015 Q2	$1.23M	Hold	170,000	–	–	0.18%	102
2015 Q1	$1.25M	Hold	170,000	–	–	0.17%	103
2014 Q4	$804K	Hold	170,000	–	–	0.11%	131
2014 Q3	$607K	Hold	170,000	–	–	0.08%	161
2014 Q2	$775K	Hold	170,000	–	–	0.1%	132
2014 Q1	$799K	Sell	170,000 -10,000	-6%	-$50.3K	0.12%	121
2013 Q4	$902K	Buy	+180,000	New	+$980K	0.15%	110

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Hollencrest Capital Management's ARRY Position: Q3 2019 in Review

Hollencrest Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 82,500 shares — an estimated $3.82M sold.

Hollencrest Capital Management first reported a position in ARRY in Q4 2013 and held it in 23 quarters. The position peaked at $3.82M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Hollencrest Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Hollencrest Capital Management sold 82,500 Array Biopharma Inc shares in Q3 2019, an estimated $3.82M.
Hollencrest Capital Management first reported a position in Array Biopharma Inc in Q4 2013 and held it in 23 quarters.
Hollencrest Capital Management's Array Biopharma Inc position peaked at $3.82M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Hollencrest Capital Management's 13F filing for Q3 2019, filed 23 Oct 2019.